RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Cocaine receptor binding ligands

Kuhar, MJ., Carroll, F., Boja, JW., Lewin, A., & Abraham, P. (2003). Cocaine receptor binding ligands. (U.S. Patent No. 6531483). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6531483

Abstract

The invention relates to novel compounds which show high affinity for cocaine receptors in the brain, particularly dopamine and serotonin transporter sites. The compounds may be used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases.

Download/Explore
Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.